HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Pitches “Tiered Model” for CEA Price Tweak, but Faces Chuikyo Opposition
November 8, 2018
-
REGULATORY FY2019 Tax Reform Debate Going into Full Swing; Will Pharma Industry Win Expansion in R&D Credit?
November 7, 2018
-
ORGANIZATION Wrong Policies Could Drive Investments Out of Japan amid China’s Rise, PhRMA Int’l Advocacy Chief Warns
November 6, 2018
-
BUSINESS Balancing Act: All Eyes on Nesp Biosame Pricing before June 2019 Listing, Biosimilars to Follow in November
November 5, 2018
-
BUSINESS 8 Major Drug Makers See Flat Sales in 1st Half; Overseas Growth Continues to Compensate for Slumping Japan Revenue
November 5, 2018
-
REGULATORY LDP’s Eto Study Group Opposes 2-Stage Revision in 2019
November 2, 2018
-
REGULATORY Chuikyo Leaning towards Drug Price Revision in October 2019 in Conjunction with Tax Hike
November 1, 2018
-
REGULATORY Infection Specialist Proposes to Set Up Vaccination Council within Cabinet Office
October 31, 2018
-
BUSINESS Shionogi Chief Confident about 70% Market Share for Xofluza in Japan
October 30, 2018
-
ORGANIZATION Limit CEA Application to Premium-Given Drugs with Big Sales: EFPIA Japan Officials
October 29, 2018
-
ORGANIZATION EFPIA Japan Chief Eyes New Funding Model for Innovative but Pricey Therapies
October 26, 2018
-
BUSINESS Tecentriq, Hemlibra Get Off with a Bang, Clear 2018 Targets Already: Chugai
October 25, 2018
-
BUSINESS AVXS-101 Is Game Changer for SMA Treatment: Novartis Neuroscience Chief
October 24, 2018
-
BUSINESS Parexel CEO Sees Bright Future for Japan CRO Market
October 23, 2018
-
BUSINESS Mundipharma Shooting for Japan Sales of US$500 Million in 10 Years: CEO
October 22, 2018
-
BUSINESS Prescribers Asked to Stop New Enbrel Biosimilar Use as Maker Can’t Keep Up with Demand
October 19, 2018
-
REGULATORY 3 Pharma Groups Warn against Drug Price Cut in April 2019: Chuikyo
October 18, 2018
-
BUSINESS JAK Inhibitor Battle for Atopic Dermatitis Intensifying, 1st Japan Filing Might Be Near
October 17, 2018
-
REGULATORY As Abe Vows to Deliver on Tax Hike Plan, 3 Pharma Groups to Push for October 2019 Price Revision
October 16, 2018
-
REGULATORY MEXT Kicks Off “Open Innovation Organization” Initiative, 3 Universities to Push Drug Discovery
October 15, 2018
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
